CAIRO: The Ministry of Health is planning to reduce the cost of domestically- produced Sovaldi, a hepatitis C treatment, to be less than the previously announced price 680 EGP ($84) per bottle at liver treatment centers, Youm7 reported Friday.
The decision to reduce the cost of the treatment is to “facilitate the patients’ accessibility to treatment, and support President Sisi’s initiative to end hepatitis C,” Tareq Salman, Assistant to Health Minister for Pharmaceutical affairs, told Youm7.
Salman previously said that the Egypt-made medicine will be available at pharmacies for 1,200 EGP, but it is planned to be subsidized further.
He further said that another locally-made Hepatitis C medicine Daklinza will be available at liver centers at cost of 200 EGP per bottle, while in markets at cost of 1,315 EGP.
Egypt has announced it started importing a “new generation” of hepatitis C drugs after having imported thousands of regimens of the U.S. medicine Sovaldi since 2014.
The new treatment regimen includes: Qurevo, Daklinza and Harvoni, which will be hitting markets in November and December.
Doctors hailed the variety in medicines that will be available for Hepatitis C patients as giving chance to find suitable cure for each case.